Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kedma Capital Partners is a leading Israeli private equity firm founded in 2006 that specializes in mid-market investments. The firm manages several funds and targets companies across various sectors, including industrials, services, and retail, primarily within the Israeli market. While not a specialized life sciences or biotech company, Kedma maintains a presence in the healthcare sector through strategic investments in service providers such as Femi Premium, a leader in telemedicine and medical management. The firm focuses on partnering with established management teams to drive operational improvements and long-term value creation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kedma Capital Partners.